Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Aus sniff-a-vax trial revealed

Posted 9 April 2021 AM

An undisclosed vaccine developer has selected Avance Clinical to initiate a first-in-human trial of its intranasal Covid vaccine in Australia.

The Adelaide-based contract research organisation has already made an application to the Office of the Gene Technology Regulatory (OGTR) to trial the genetically modified human adenovirus vaccine but is keeping under wraps who developed it.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
All fine, nothing to see here
How politics made a mess of the rollout
Special Report
PBAC July Agenda
Committee to assess 36 submissions
Approvals Action
First copy of gout drug
Plus new formulations of PBS-listed drugs
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas